SPECIALTY LABORATORIES REPORTS THIRD QUARTER FINANCIAL PERFORMANCE THIRD QUARTER FINANCIAL REPORTS for Specialty Laboratories, Inc. show that the company is returning to a more normal routine, following the two unusual and unrelated events which hit it during 2002. Specialty Labs reported net revenue of $29.9 million for third quarter 2003. This is a decline of …
Specialty Laboratories, Enterix, Medicare, Blue Cross/Blue Shield Association Read More »
To access this post, you must purchase The Dark Report.